Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ELIZABETH D. AVARICIO, MD, PLLC

NPI: 1538586458 · OZONE PARK, NY 11416 · Pediatrics Physician · NPI assigned 03/28/2014

$3.52M
Total Medicaid Paid
110,133
Total Claims
104,195
Beneficiaries
60
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialAVARICIO, ELIZABETH (MEDICAL DOCTOR)
NPI Enumeration Date03/28/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 9,681 $340K
2019 16,310 $511K
2020 16,651 $450K
2021 17,779 $506K
2022 18,691 $624K
2023 15,843 $564K
2024 15,178 $524K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18,203 16,066 $1.22M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,593 4,353 $413K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,390 4,370 $360K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,186 4,180 $347K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,875 2,873 $264K
90460 Immunization administration through 18 years of age via any route, first or only component 12,244 12,087 $262K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3,100 3,045 $235K
90461 4,681 4,657 $137K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,709 1,588 $73K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,243 2,685 $54K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 251 251 $23K
92587 622 618 $20K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,780 3,671 $20K
90671 215 215 $17K
90697 159 159 $13K
96127 3,388 3,385 $8K
90651 877 871 $8K
99072 3,357 3,182 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 334 297 $6K
99381 63 62 $5K
99441 107 103 $4K
90670 2,194 2,184 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 299 289 $3K
86580 658 644 $3K
81003 1,627 1,601 $2K
90686 2,995 2,991 $2K
90619 166 166 $1K
99383 12 12 $1K
90656 271 271 $768.29
90715 388 386 $586.71
99173 2,372 2,360 $444.80
90688 1,566 1,557 $442.10
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 21 21 $409.57
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 310 301 $408.96
96380 29 29 $397.32
90734 796 794 $331.46
92567 22 22 $252.45
90710 1,246 1,237 $243.81
90655 24 24 $189.75
90744 1,060 1,055 $118.46
A7015 Aerosol mask, used with dme nebulizer 269 260 $105.52
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 12 12 $71.92
90633 1,372 1,368 $37.35
36415 Collection of venous blood by venipuncture 7,916 7,788 $33.38
99406 24 24 $22.00
36410 26 26 $11.94
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 267 261 $11.13
90698 1,688 1,680 $0.00
90647 349 347 $0.00
3008F 5,559 5,558 $0.00
99000 91 91 $0.00
90696 455 452 $0.00
96110 Developmental screening, with scoring and documentation, per standardized instrument 25 25 $0.00
94660 15 13 $0.00
90681 1,058 1,055 $0.00
90685 72 71 $0.00
90700 389 389 $0.00
99408 24 24 $0.00
90713 57 57 $0.00
90687 32 32 $0.00